Antibiotic Resistance Diagnostics & Treatment Market Overview

According to FutureWise analysis the market for Antibiotic Resistance in 2023 was US$ 8.61 million, and is expected to register a CAGR of 5.90% in 2023-2031

Antibiotics are essential medications used for the prevention and treatment of bacterial infections. However, a growing concern in healthcare is antimicrobial resistance, which occurs when microorganisms, including bacteria and fungi, develop the ability to resist the effects of the drugs intended to eliminate them. This resistance is exacerbated by the misuse and overuse of antibiotics, as well as inadequate infection prevention and management practices. Infections caused by resistant microbes can often be challenging, and sometimes even impossible, to treat effectively.

Antibiotic resistance is a natural phenomenon; nevertheless, the increase in resistance cases is largely influenced by the exposure of microorganisms to antibiotics and antifungals. This exposure allows resistant strains to proliferate and can lead to their transmission along with the resistance traits to other bacteria during reproduction. Furthermore, spontaneous mutations in the genetic material of bacteria can also contribute to the development of resistance.

Antibiotic resistance is categorized into several types, such as complicated urinary tract infections (cUTIs), bloodstream infections (CDIs), complicated intra-abdominal infections (cIAIs), and Clostridium difficile infections (CDIs). Complicated urinary tract infections (cUTIs) particularly affect individuals with various underlying issues related to the genitourinary tract, which can include functional, structural, or metabolic abnormalities. These infections are often caused by multidrug-resistant Gram-negative bacilli and pose significant risks, including the potential for untreated or resistant cases to lead to kidney complications, such as pyelonephritis, or more severe conditions like sepsis or urosepsis. Additionally, living with the persistent symptoms of recurrent or antibiotic-resistant urinary tract infections can be extremely challenging for affected individuals.

FutureWise Market Research has published a report that provides an insightful analysis of Antibiotic Resistance Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=11652&type=requestsample

Antibiotic Resistance Market Segmentation:

By Disease

• Complicated Urinary Tract Infection (cUTI)
• Complicated Intra-Abdominal Infections (cIAI)
• Blood Stream Infections (BSI)
• Clostridium difficile infections (CDI)
• Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
• Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
• Community Acquired Bacterial Pneumonia (CABP)

By Pathogen

• Acinetobacter baumannii (Carbapenem-Resistant and ESBL-producing)
• Pseudomonas aeruginosa (Carbapenem-Resistant)
• Staphylococcus Aureus (Methicillin-Resistant)
• E.coli/K. pneumoniae (Carbapenem-Resistant)
• Streptococcus pneumoniae (Penicillin-Non-Susceptible)
• Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant)
• Enterococcus faecium (Vancomycin-Resistant)
• Haemophilus Influenzae (Ampicillin-Resistant)

By Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Cephalosporins
• Combination therapies
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Antibiotic Resistance Market:

• Achaogen, Inc.
• Basilea Pharmaceutica Ltd.
• Melinta Therapeutics
• Tetraphase Pharmaceuticals, Inc.
• Theravance Biopharma, Inc.
• Wockhardt therapeutics
• Entasis Therapeutics
• Paratek therapeutics
• Seres Therapeutics, Inc.
• Pfizer
• Merck
• Allergan
• Pall Corporation
• Cytiva
• Bio-Rad Laboratories

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=11652&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Antibiotic Resistance Market By Disease, By Pathogen, By Drug Class and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/75574-Antibiotic-Resistance-Diagnostics-and-Treatment-Market-Overview.html